Placebo controlled pilot study on the efficacy of levocetirizine 5 mg in reducing symptoms, airway resistance, and sleep impairment in patients with persistent allergic rhinitis

Trial Profile

Placebo controlled pilot study on the efficacy of levocetirizine 5 mg in reducing symptoms, airway resistance, and sleep impairment in patients with persistent allergic rhinitis

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Oct 2014

At a glance

  • Drugs Levocetirizine (Primary)
  • Indications Perennial allergic rhinitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Oct 2009 Actual patient number (100) added as reported by ClinicalTrials.gov.
    • 20 Oct 2009 Actual end date (Nov 2007) added as reported by ClinicalTrials.gov.
    • 14 Jan 2008 Status changed from recruiting to completed according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top